Cas:5973-06-8 β-amyrin palmitate manufacturer & supplier

We serve Chemical Name:β-amyrin palmitate CAS:5973-06-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

β-amyrin palmitate

Chemical Name:β-amyrin palmitate
CAS.NO:5973-06-8
Synonyms:Hexadecanoic acid, (3β)-olean-12-en-3-yl ester;Olean-12-en-3-ol, hexadecanoate, (3β)-;β-amyrin palmitate;(3β)-Olean-12-en-3-yl palmitate;Balanophorin {Palmitate}
Molecular Formula:C46H80O2
Molecular Weight:665.126
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:661.4±54.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.516
PSA:26.30000
Exact Mass:664.615845
LogP:19.39

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Hexadecanoic acid, (3β)-olean-12-en-3-yl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Balanophorin {Palmitate} physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,β-amyrin palmitate Use and application,Hexadecanoic acid, (3β)-olean-12-en-3-yl ester technical grade,usp/ep/jp grade.


Related News: Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. alumane,molybdenum(4:1) manufacturers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. sodium 2-(5-(benzo[b]thiophen-2-yl)-3-(5-chlorothiophen-2-yl)furan-2-yl)acetate suppliers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. iron,tin (3:2) vendor & factory.